THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT

Soysal T., Eskazan A. E., Sadri S., Erdogan I., Berk S., Yalniz F. F., ...More

20th Congress of European-Hematology-Association, Vienna, Austria, 11 - 14 June 2015, vol.100, pp.447, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 100
• City: Vienna
• Country: Austria
• Page Numbers: pp.447
• Istanbul University-Cerrahpasa Affiliated: No